USPTO serial 97372045
KYFORA BIO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 24, 2024
- Examiner
- EISNACH, MICHAEL PATRICK
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with KYFORA BIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David M. Tener, Esq.
David M. Tener, Esq. CAESAR RIVISE, PC1635 MARKET STREET7 PENN CENTER, 12TH FLOORPHILADELPHIA, PA 19103Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Chemical preparations for medical use for research and for genetic diagnostics, namely, for the discovery, development and delivery of cell and gene therapies for treating genetic diseases; Diagnostic agents for medical use for research and for genetic diagnostics; Reagents for medical use for research and for genetic diagnostics; Chemical and biochemical diagnostic reagent test kits for medical and clinical use comprised of medical diagnostic preparations, agents and reagents for use in disease testing; Medicines for the treatment of genetic diseases | ACTIVE | — |
| 042 | Analyses in the field of molecular biology; Analysis of the chemical composition of liquids; Chemical analysis; Chemical and biochemical analyses; Chemical engineering services; Chemical laboratory services; Chemical research; Chemical technology research; Computer-aided scientific testing of DNA samples for diagnostic purposes; Scientific research in the nature of conducting clinical trials for others for pharmaceutical and genetic products; Consultancy in the field of pharmaceutical research; Consulting in relation to research and development of transfections agents and agents, reagents and chemicals and biochemicals used in the field of genetics; Development of new products in the field of gene therapy; Development of pharmaceutical preparations and medicines; Development of pharmaceutical products; Testing and evaluation of chemicals; Genetic analyses for scientific research purposes; Industrial packaging design services; Inspection of pharmaceutical products; Laboratory research in the field of genetics; Laboratory research services concerning pharmaceutical products; Pharmaceutical product development services; Pharmaceutical research services; Provision of information concerning the results of clinical trials for pharmaceutical products; Quality evaluation of pharmaceutical products; Research and development for the pharmaceutical industry; Research and development of new products for third parties; Research in the field of pharmaceutical products; Scientific analyses and research in the field of transfection; Scientific development of transfection agents; Scientific research for medical purposes in the field of genetics and genetic engineering; Scientific research in the field of genetics and genetic engineering; Scientific research in the field of medicines; Scientific testing services in the field of genetics; Services of a genetic research laboratory, namely, genetic testing for scientific research purposes and development of gene therapies for medical purposes; Software design and computer software design in the field of scientific research and genetic analyses; Structural and functional analysis of genomes; Testing of chemical products; Testing on pharmaceutical products | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by The Ott Group, Inc.
- Other trademarks owned by The Ott Group, Inc.
- Other trademarks owned by KYFORA BIO, LLC
- Other trademarks owned by KYFORA BIO, LLC
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named KYFORA BIO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 24, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 24, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 3, 2024 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Dec 3, 2024 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Dec 2, 2024 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Nov 21, 2024 | IUAF | USE AMENDMENT FILED | — |
| Nov 21, 2024 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jul 18, 2024 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Jul 18, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 18, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 18, 2024 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Jun 28, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 24, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 24, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 24, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 22, 2024 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| May 21, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| May 21, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 2, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 2, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 2, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 27, 2024 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Nov 21, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 26, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 26, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 6, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 21, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 15, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 14, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 14, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 15, 2023 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| May 15, 2023 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Feb 14, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 7, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 26, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 23, 2022 | NWAP | NEW APPLICATION ENTERED | — |